{Reference Type}: Journal Article
{Title}: Evaluation of a Capped Dosing Telavancin Regimen Compared to Standard Dosing at a Large Community Teaching Hospital.
{Author}: Diggs FJ;Edwards JD;Garza KB;Hassoun AAM;Durham SH;
{Journal}: Antimicrob Agents Chemother
{Volume}: 66
{Issue}: 1
{Year}: 01 2022 18
{Factor}: 5.938
{DOI}: 10.1128/AAC.01603-21
{Abstract}: Telavancin, a lipoglycopeptide antibiotic, is traditionally dosed at 10 mg/kg based on total body weight but is associated with toxicities that limit its use. This study supports the use of a capped dosing regimen of 750 mg in obese patients, which is associated with equal efficacy and fewer adverse effects compared to traditional dosing.